We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$548M
AUM Growth
+$7.66M
Cap. Flow
-$12M
Cap. Flow %
-2.19%
Top 10 Hldgs %
32.65%
Holding
154
New
7
Increased
23
Reduced
102
Closed
2

Top Buys

Rank Stock Value
1
OTTR icon
Otter Tail
OTTR
+$3.75M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$2.15M
3
TEX icon
Terex
TEX
+$1.98M
4
ALTR
Altera Corp
ALTR
+$1.38M
5
CMC icon
Commercial Metals
CMC
+$1.25M

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$4.98M
2
STE icon
Steris
STE
+$4.1M
3
FCX icon
Freeport-McMoran
FCX
+$2.26M
4
ADI icon
Analog Devices
ADI
+$2.16M
5
JNJ icon
Johnson & Johnson
JNJ
+$1.91M

Sector Composition

Rank Sector Weight
1 Healthcare 24.56%
2 Industrials 20.41%
3 Technology 17.84%
4 Energy 9.49%
5 Utilities 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$646B
$31M 5.66%
296,132
-18,931
-6% -$1.91M
GLW icon
2
Corning
GLW
$128B
$24.1M 4.4%
1,097,433
-88,269
-7% -$1.87M
XOM icon
3
ExxonMobil
XOM
$644B
$22.5M 4.11%
223,696
-8,620
-4% -$870K
EMR icon
4
Emerson Electric
EMR
$86.6B
$17.7M 3.23%
266,873
+9,178
+4% +$617K
KO icon
5
Coca-Cola
KO
$386B
$16.5M 3.02%
390,036
+17,445
+5% +$708K
INTC icon
6
Intel
INTC
$473B
$15.8M 2.89%
512,452
-8,540
-2% -$234K
SLB icon
7
SLB Ltd
SLB
$85.1B
$15.1M 2.76%
128,073
-2,950
-2% -$304K
PLL
8
DELISTED
PALL CORP
PLL
$12.2M 2.22%
142,413
-3,888
-3% -$333K
MRK icon
9
Merck
MRK
$366B
$12.1M 2.21%
219,251
-5,030
-2% -$274K
PFE icon
10
Pfizer
PFE
$159B
$11.7M 2.14%
416,504
+34,081
+9% +$971K
BMY icon
11
Bristol-Myers Squibb
BMY
$136B
$11.1M 2.02%
228,402
-4,150
-2% -$205K
GSK icon
12
GSK
GSK
$102B
$11M 2.01%
164,884
+7,595
+5% +$514K
IBM icon
13
IBM
IBM
$222B
$10.6M 1.93%
60,880
-2,537
-4% -$457K
GXP
14
DELISTED
Great Plains Energy Incorporated
GXP
$10.4M 1.9%
386,180
-7,400
-2% -$193K
MSFT icon
15
Microsoft
MSFT
$3.81T
$10.2M 1.86%
244,849
-5,700
-2% -$231K
GVA icon
16
Granite Construction
GVA
$5.44B
$8.97M 1.64%
249,342
-12,350
-5% -$451K
MMM icon
17
3M
MMM
$89.9B
$8.62M 1.57%
71,941
-2,420
-3% -$284K
HON icon
18
Honeywell
HON
$68.9B
$8.61M 1.57%
103,141
-3,005
-3% -$251K
BCE icon
19
BCE
BCE
$21.9B
$8.39M 1.53%
184,949
-3,500
-2% -$158K
CSCO icon
20
Cisco
CSCO
$433B
$7.88M 1.44%
316,945
-375
-0.1% -$8.94K
IDA icon
21
Idacorp
IDA
$7.85B
$7.87M 1.44%
136,015
-2,150
-2% -$119K
AMGN icon
22
Amgen
AMGN
$234B
$7.56M 1.38%
63,847
-1,675
-3% -$194K
DRC
23
DELISTED
DRESSER-RAND GROUP INC
DRC
$7.54M 1.38%
118,385
-300
-0.3% -$18.3K
NVS icon
24
Novartis
NVS
$292B
$7.26M 1.33%
89,547
-1,674
-2% -$132K
AZTA icon
25
Azenta
AZTA
$1.44B
$7.01M 1.28%
651,288
+68,100
+12% +$687K
1
2 3 4 5

Similar funds

SWIG
Strategic Wealth Investment Group Louisville, Kentucky $825M AUM 11.63% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $824M AUM 40.45% 1-Year Est. Return
WRPWM
Werba Rubin Papier Wealth Management San Jose, California $824M AUM 24.76% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $823M AUM 36.99% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $826M AUM 47.87% 1-Year Est. Return
MGAM
McGowan Group Asset Management Dallas, Texas $823M AUM 27.48% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $826M AUM 21.35% 1-Year Est. Return

John G. Ullman & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, John G. Ullman & Associates held 154 positions worth $548M, up 1.4% from $540M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q2 2014 filing shows 7 new, 23 increased, 102 reduced and 2 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 47,646 shares worth $2.45M. The largest sale was Exelon, an estimated $4.98M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q2 2014 buy was State Street SPDR S&P Biotech ETF: 47,646 shares worth $2.45M.
  • John G. Ullman & Associates added most to Otter Tail in Q2 2014, an estimated $3.75M increase.
  • John G. Ullman & Associates's biggest Q2 2014 reduction was Exelon, cutting an estimated $4.98M.
  • John G. Ullman & Associates fully exited Halliburton in Q2 2014, selling an estimated $707K.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $548M portfolio in Q2 2014.
  • John G. Ullman & Associates opened 7 new positions and closed 2 in Q2 2014.
  • John G. Ullman & Associates's portfolio value rose 1.4% quarter-over-quarter to $548M.

Based on John G. Ullman & Associates's 13F filing for Q2 2014, filed 18 Jul 2014.